46.28

5.35% 2.35

After Hours: 46.28

Corcept Therapeutics Inc (CORT)

Overview News Price History Option Chain Financials Why CORT Down? Discussions Forecast

Corcept Therapeutics Inc stock is traded at $46.28, with a volume of 1.53M. It is up +5.35% in the last 24 hours and up +31.10% over the past month. Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Previous Close:

$43.93

Open:

$44.37

24h Volume:

1.53M

Relative Volume:

1.82

Market Cap:

$4.87B

Revenue:

$523.53M

Net Income/Loss:

$118.02M

P/E Ratio:

57.14

EPS:

0.81

Net Cash Flow:

$124.84M

1W Performance:

+7.75%

1M Performance:

+31.10%

6M Performance:

+83.72%

1Y Performance:

+69.87%

1-Day Range:

$44.15

$47.33

1-Week Range:

$42.17

$47.33

52-Week Range:

$20.84

$47.33

Corcept Therapeutics Inc Stock (CORT) Company Profile

Name

Corcept Therapeutics Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

650.688.8803

Address

149 COMMONWEALTH DRIVE, MENLO PARK

Employee

352

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

CORT's Discussions on Twitter

Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-06-23	Upgrade	Truist	Hold → Buy
Apr-11-23	Initiated	SVB Securities	Market Perform
Apr-04-23	Initiated	Piper Sandler	Overweight
Feb-15-23	Downgrade	Jefferies	Buy → Hold
Aug-01-22	Downgrade	Truist	Buy → Hold
Jul-27-22	Upgrade	Jefferies	Hold → Buy
Jun-27-22	Resumed	Canaccord Genuity	Buy
Feb-02-22	Initiated	Canaccord Genuity	Buy
Jan-28-22	Initiated	Truist	Buy
Aug-05-20	Downgrade	Jefferies	Buy → Hold
Sep-24-19	Initiated	Jefferies	Buy
Sep-06-19	Initiated	H.C. Wainwright	Buy
Feb-04-19	Downgrade	B. Riley FBR	Buy → Neutral
Aug-10-18	Reiterated	Stifel	Hold
May-31-18	Downgrade	Stifel	Buy → Hold
Mar-09-18	Initiated	B. Riley FBR, Inc.	Buy
Aug-31-17	Initiated	Stifel	Buy
Feb-02-17	Initiated	Ladenburg Thalmann	Buy
Apr-21-15	Initiated	FBR Capital	Outperform
Jan-13-14	Downgrade	Stifel	Buy → Hold
Aug-09-13	Downgrade	Janney	Buy → Neutral
Aug-09-13	Downgrade	Ladenburg Thalmann	Buy → Neutral
Feb-21-12	Reiterated	JMP Securities	Mkt Outperform
Jan-06-10	Upgrade	Ladenburg Thalmann	Neutral → Buy
Jul-17-08	Initiated	Rodman & Renshaw	Mkt Outperform
Jun-21-07	Upgrade	Punk, Ziegel & Co	Mkt Perform → Accumulate

View All

Corcept Therapeutics Inc Stock (CORT) Latest News

03:01 AM

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast - Yahoo Canada Finance

03:01 AM

12:59 PM

A Look at Corcept Therapeutics Inc (CORT) Shares in the Recent Past Indicates Growth - SETE News

12:59 PM

11:14 AM

Corcept Therapeutics (NASDAQ:CORT) PT Raised to $76.00 - MarketBeat

11:14 AM

10:34 AM

Corcept Therapeutics (NASDAQ:CORT) Hits New 1-Year High at $45.26 - MarketBeat

10:34 AM

02:16 AM

FY2026 Earnings Estimate for Corcept Therapeutics Incorporated Issued By Zacks Research (NASDAQ:CORT) - Defense World

02:16 AM

Sep 29, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Holdings Reduced by D. E. Shaw & Co. Inc. - Defense World

Sep 29, 2024

Evergreen Capital Management LLC Invests $217,000 in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Sep 29, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Holdings Reduced by D. E. Shaw & Co. Inc. - MarketBeat

Sep 29, 2024

Sep 27, 2024

Equities Analysts Issue Forecasts for Corcept Therapeutics Incorporated's Q1 2025 Earnings (NASDAQ:CORT) - MarketBeat

Sep 27, 2024

Insider Selling: Guyer William, Corcept Therapeutics Inc [CORT] Chief Development Officer divested 10,000 shares - Knox Daily

Sep 27, 2024

Sep 26, 2024

Profund Advisors LLC Sells 6,260 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Sep 26, 2024

Sep 25, 2024

Financial Metrics Exploration: Understanding Corcept Therapeutics Inc (CORT) Through Ratios - The Dwinnex

Sep 25, 2024

Public Sector Pension Investment Board Acquires 15,661 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Sep 25, 2024

Does Corcept Therapeutics (CORT) Have a Long Runway for Growth? - Yahoo Finance

Sep 25, 2024

CORT overperforms with a 2.44 increase in share price - US Post News

Sep 25, 2024

Public Sector Pension Investment Board Buys 15,661 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Sep 25, 2024

Big Money All Over Corcept Shares - Yahoo Finance

Sep 25, 2024

Sep 24, 2024